Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer.

Barton DP, Blanchard DK, Wells AF, Nicosia SV, Roberts WS, Cavanagh D, Djeu JY.

Anticancer Res. 1994 May-Jun;14(3A):761-72.

PMID:
8074478
[PubMed - indexed for MEDLINE]
2.

High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer.

Barton DP, Blanchard DK, Michelini-Norris B, Nicosia SV, Cavanagh D, Djeu JY.

Blood. 1993 Jan 15;81(2):424-9.

PMID:
8422462
[PubMed - indexed for MEDLINE]
Free Article
3.

The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.

Elg SA, Hill RB, Heldman L, Ramakrishnan S.

Gynecol Oncol. 1997 Jul;66(1):133-7.

PMID:
9234933
[PubMed - indexed for MEDLINE]
4.

Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.

Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL.

Int J Cancer. 1992 Jun 19;51(4):573-80.

PMID:
1601521
[PubMed - indexed for MEDLINE]
5.

High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.

Macciò A, Lai P, Santona MC, Pagliara L, Melis GB, Mantovani G.

Gynecol Oncol. 1998 Jun;69(3):248-52.

PMID:
9648596
[PubMed - indexed for MEDLINE]
6.

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB.

Cancer. 1995 Nov 1;76(9):1615-20.

PMID:
8635066
[PubMed - indexed for MEDLINE]
7.

In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis.

Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R.

Kidney Int. 1993 Mar;43(3):682-92.

PMID:
8455368
[PubMed - indexed for MEDLINE]
8.

Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients.

Hurteau JA, Simon HU, Kurman C, Rubin L, Mills GB.

Am J Obstet Gynecol. 1994 Mar;170(3):918-28.

PMID:
8141226
[PubMed - indexed for MEDLINE]
9.

Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.

Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, Vermersch A, Fenaux P, Bletry O, Capron M.

Blood. 1991 Nov 15;78(10):2626-32.

PMID:
1726707
[PubMed - indexed for MEDLINE]
Free Article
10.

Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.

Treiber-Held S, Stewart DM, Barraclough HA, Kurman CC, Nelson DL.

Clin Immunol Immunopathol. 1996 Jul;80(1):67-75.

PMID:
8674241
[PubMed - indexed for MEDLINE]
11.

Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.

Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY.

J Soc Gynecol Investig. 1995 Nov-Dec;2(6):762-71.

PMID:
9420887
[PubMed - indexed for MEDLINE]
12.

Serum soluble interleukin-2 receptor alpha levels in patients with gynecologic cancers: early effect of surgery.

Barton DP, Blanchard DK, Michelini-Norris B, Roberts WS, Hoffman MS, Fiorica JV, Nicosia SV, Cavanagh D, Djeu JY.

Am J Reprod Immunol. 1993 Sep-Oct;30(2-3):202-6.

PMID:
8311929
[PubMed - indexed for MEDLINE]
13.

Induction of the interleukin-2 receptor (p55) by interferons.

Onji M, Yamaguchi S, Masumoto T, Akbar SM, Kajino K, Ohta Y.

J Interferon Res. 1991 Aug;11(4):237-41.

PMID:
1680935
[PubMed - indexed for MEDLINE]
14.
15.

The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.

Berghella AM, Pellegrini P, Del Beato T, Marini M, Tomei E, Adorno D, Casciani CU.

Cancer Immunol Immunother. 1998 Jan;45(5):241-9.

PMID:
9439647
[PubMed - indexed for MEDLINE]
16.

Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.

Kusuda T, Shigemasa K, Arihiro K, Fujii T, Nagai N, Ohama K.

Oncol Rep. 2005 Jun;13(6):1153-8.

PMID:
15870936
[PubMed - indexed for MEDLINE]
17.
18.

Elevated serum-soluble interleukin-2 receptor (Tac antigen) levels in chronic myelogenous leukemia patients with blastic crisis.

Motoi T, Uchiyama T, Hori T, Itoh K, Uchino H, Ueda R.

Blood. 1989 Aug 15;74(3):1052-7.

PMID:
2787681
[PubMed - indexed for MEDLINE]
Free Article
19.

Serum and cystic fluid levels of soluble interleukin-2 receptor-alpha in patients with epithelial ovarian tumors are correlated.

de Bruijn HW, ten Hoor KA, van der Zee AG.

Tumour Biol. 1998;19(3):160-6.

PMID:
9591042
[PubMed - indexed for MEDLINE]
20.

Immune activation genes in inflammatory bowel disease.

Matsuura T, West GA, Youngman KR, Klein JS, Fiocchi C.

Gastroenterology. 1993 Feb;104(2):448-58.

PMID:
8425687
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk